About Enovis Corp
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.enovis.com/
Frequently Asked Questions
What is the 52-week range for ENOV?
The 52-week high is $34.28 and the 52-week low is $17.3.
What is the P/E ratio for ENOV?
The P/E ratio data is currently unavailable.
What is the dividend yield for ENOV?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -68.17%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -47.97%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.02.
Analyst Recommendation Trends
Wall Street analyst consensus for ENOV over the last few months:
Latest ENOV News
1 Oversold Stock Ready to Bounce Back and 2 That Underwhelm
Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investor’s dilemma: bargain opportunity or value trap?
Sports Rehabilitation Equipment Market Global Report 2026: Capitalize on a $2.05 Billion Revenue Surge to $6.84 Billion by 2030 as AI and Robotics Disrupt Recovery—Benchmark Stryker, Smith & Nephew, Enovis, Performance Health and Life Fitness
Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Sports Rehabilitation Equipment Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global sports rehabilitation equipment market is experiencing strong growth, driven by the rising incidence of sports injuries, expanding physiotherapy services and increasing awareness of rehabilitation therapies. The market is projected to grow from $4.39 billion in 2025 to $4.79 billion in 2026, representing a compound annual growth ra
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
The American Academy of Orthopaedic Surgeons (AAOS) announced that Enovis™ has expanded its support of the AAOS Registry Program, becoming the first industry partner to sponsor multiple AAOS registries. A longtime sponsor of the American Joint Replacement Registry (AJRR), Enovis will now also support the Shoulder & Elbow Registry (SER) through 2027.
2 Russell 2000 Stocks on Our Watchlist and 1 We Brush Off
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
Shareholders of Enovis would probably like to forget the past six months even happened. The stock dropped 20.4% and now trades at $18.67. This may have investors wondering how to approach the situation.
Insider at Medical Device Maker Buys More Than 7,500 Shares
Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline.
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Enovis (NYSE:ENOV) and its peers.
Enovis (ENOV) Stock Fair Value Falls As Analysts Weigh Robotics And Margin Pressure
Enovis is back in focus for investors after a modest reset in its implied price target, with fair value in one model shifting from US$42.30 to about US$38.33. Analysts link this move to fresh thinking on the eCential Robotics acquisition, recent free cash flow trends, and the latest Q2 read through to growth plans and execution risk. As you read on, you will see how these moving parts shape the evolving Enovis story and what to watch next in the analyst narrative. Stay updated as the Fair...
What Makes Enovis (ENOV) a New Buy Stock
Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Avenzo Therapeutics Announces Appointment of Barbara Bodem and Elizabeth Mily to Board of Directors as Independent Directors
SAN DIEGO, September 03, 2026--Avenzo Therapeutics Announces Appointment of Barbara Bodem and Elizabeth Mily to Board of Directors as Independent Directors
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-30 | Ortiz Christine | +958 | - | - |
| 2026-09-04 | Engert Oliver | +2,660 | $18.8 | $50,008 |
| 2026-09-04 | McDonald Damien | +13,035 | $19.15 | $249,620 |
| 2026-09-03 | Engert Oliver | +5,140 | $19.46 | $100,024 |
| 2026-09-02 | Engert Oliver | +2,458 | $20.32 | $49,947 |
| 2026-06-30 | Ortiz Christine | +846 | - | - |
| 2026-06-15 | Engert Oliver | +1,000 | $20.92 | $20,920 |
| 2026-06-11 | Engert Oliver | +1,000 | $20.99 | $20,990 |
| 2026-06-11 | Engert Oliver | +1,000 | $21.75 | $21,750 |
| 2026-06-11 | Engert Oliver | +200 | $20.99 | $4,198 |
| 2026-06-10 | Engert Oliver | +1,000 | $23 | $23,000 |
| 2026-06-01 | Engert Oliver | +1,000 | $22.22 | $22,220 |
| 2026-05-19 | Shirley Brady | +9,346 | - | - |
| 2026-05-19 | Bodem Barbara W. | +9,346 | - | - |
| 2026-05-19 | Okala Philip | +9,346 | - | - |
| 2026-05-19 | Ortiz Christine | +9,346 | - | - |
| 2026-05-19 | Kelly Liam | +9,346 | - | - |
| 2026-05-19 | Vinnakota Rajiv | +9,346 | - | - |
| 2026-05-19 | Wienbar Sharon L | +9,346 | - | - |
| 2026-05-19 | Lalor Angela S | +9,346 | - | - |
| 2026-05-19 | PERFALL A CLAYTON | +9,346 | - | - |
| 2026-05-12 | McDonald Damien | -12,634 | $25.99 | $328,358 |
| 2026-05-12 | BERRY PHILLIP BENJAMIN (BEN) | -7,774 | $25.99 | $202,046 |
| 2026-03-31 | Ortiz Christine | +770 | - | - |
| 2026-03-13 | Engert Oliver | +1,000 | $23.74 | $23,740 |
| 2026-03-10 | Engert Oliver | +1,000 | $23.93 | $23,930 |
| 2026-03-09 | KLECKNER JOHN | +14,925 | - | - |
| 2026-03-09 | ROSS TERRY D | +36,247 | - | - |
| 2026-03-09 | Lang Patricia A | +25,586 | - | - |
| 2026-03-09 | VOGT LOUIS | +36,247 | - | - |
| 2026-03-09 | BERRY PHILLIP BENJAMIN (BEN) | +47,974 | - | - |
| 2026-03-09 | McDonald Damien | +143,923 | - | - |
| 2026-03-09 | Engert Oliver | +1,000 | $23.39 | $23,390 |
| 2026-03-09 | Tandy Bradley J | +25,586 | - | - |
| 2026-03-07 | KLECKNER JOHN | -586 | $24.51 | $14,363 |
| 2026-03-07 | ROSS TERRY D | -2,376 | $24.51 | $58,236 |
| 2026-03-07 | Lang Patricia A | -2,969 | $24.51 | $72,770 |
| 2026-03-07 | VOGT LOUIS | -1,980 | $24.51 | $48,530 |
| 2026-03-07 | BERRY PHILLIP BENJAMIN (BEN) | -3,167 | $24.51 | $77,623 |
| 2026-03-07 | Tandy Bradley J | -1,874 | $24.51 | $45,932 |
| 2026-03-06 | Engert Oliver | +500 | $24.48 | $12,240 |
| 2026-03-06 | Engert Oliver | +250 | $24.28 | $6,070 |
| 2026-03-04 | ROSS TERRY D | -765 | $25.79 | $19,729 |
| 2026-03-04 | KLECKNER JOHN | -442 | $25.79 | $11,399 |
| 2026-03-04 | Shirley Brady | -3,059 | $25.79 | $78,892 |
| 2026-03-04 | BERRY PHILLIP BENJAMIN (BEN) | -2,220 | $25.79 | $57,254 |
| 2026-03-04 | VOGT LOUIS | -888 | $25.79 | $22,902 |
| 2026-03-04 | Lang Patricia A | -1,173 | $25.79 | $30,252 |
| 2026-03-04 | Tandy Bradley J | -1,102 | $25.79 | $28,421 |
| 2026-03-04 | Engert Oliver | +250 | $25.1 | $6,275 |
| 2026-03-03 | Engert Oliver | +1,000 | $24.77 | $24,770 |
| 2026-02-28 | Lang Patricia A | -497 | $25.47 | $12,659 |
| 2026-02-28 | VOGT LOUIS | -889 | $25.47 | $22,643 |
| 2026-02-28 | ROSS TERRY D | -418 | $25.47 | $10,646 |
| 2026-02-28 | Shirley Brady | -1,492 | $25.47 | $38,001 |
| 2026-02-28 | KLECKNER JOHN | -315 | $25.47 | $8,023 |
| 2026-02-28 | BERRY PHILLIP BENJAMIN (BEN) | -720 | $25.47 | $18,338 |
| 2026-02-28 | Tandy Bradley J | -484 | $25.47 | $12,327 |
| 2026-02-27 | Engert Oliver | +1,000 | $25.5 | $25,500 |
| 2026-01-05 | Engert Oliver | +42,640 | - | - |
| 2025-12-31 | Lalor Angela S | +845 | - | - |
| 2025-12-09 | PRYOR DANIEL A | -333 | $27.22 | $9,064 |
| 2025-12-09 | PRYOR DANIEL A | -333 | $27.18 | $9,051 |
| 2025-12-09 | PRYOR DANIEL A | -333 | $27.21 | $9,061 |
| 2025-12-09 | PRYOR DANIEL A | -666 | $27.21 | $18,122 |
| 2025-11-25 | KLECKNER JOHN | +2,468 | $30.32 | $74,830 |